AC Immune SA - SHS (ACIU)

Historical Holders from Q3 2016 to Q3 2025

Symbol
ACIU on Nasdaq
Type / Class
Equity / SHS
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
24,623,944
Holdings value
$71,148,777
% of all portfolios
0%
Number of holders
40
Number of buys
17
Number of sells
18
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
48 filings reported holding ACIU - AC Immune SA - SHS as of 30 Sep 2025.
AC Immune SA - SHS (ACIU) has 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24,623,944 shares of stock. of the company stock as of 30 Sep 2025.

Institutional Holders of AC Immune SA - SHS (ACIU) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 24,623,944 $71,148,777 +$686,928 $2.89 40
2025 Q2 24,501,946 $49,722,343 -$2,756,926 $2.03 41
2025 Q1 25,917,900 $48,452,492 -$3,728,124 $1.87 40
2024 Q4 27,368,510 $73,887,369 -$2,737,104 $2.70 44
2024 Q3 28,199,176 $106,590,963 -$1,853,215 $3.78 44
2024 Q2 28,573,335 $114,006,597 -$1,281,277 $3.99 45
2024 Q1 28,963,669 $85,732,267 -$1,862,840 $2.96 36
2023 Q4 29,638,667 $148,194,005 +$66,221,274 $5.00 32
2023 Q3 15,980,878 $45,546,797 -$163,679 $2.85 26
2023 Q2 16,033,528 $47,379,324 +$6,282,077 $2.96 32
2023 Q1 14,097,734 $32,988,033 -$1,216,478 $2.34 32
2022 Q4 14,762,259 $30,113,226 +$1,536,126 $2.04 36
2022 Q3 14,018,294 $44,297,207 +$517,551 $3.16 30
2022 Q2 13,801,201 $49,819,603 -$1,927,044 $3.61 31
2022 Q1 14,291,564 $57,165,356 -$3,450,896 $4.00 33
2021 Q4 15,047,465 $74,485,031 -$21,762,511 $4.95 42
2021 Q3 17,659,476 $118,498,474 -$4,033,421 $6.71 62
2021 Q2 18,193,441 $144,277,000 +$813,654 $7.93 56
2021 Q1 18,204,501 $138,526,610 -$11,324,869 $7.61 51
2020 Q4 18,802,256 $97,207,000 -$3,656,172 $5.17 42
2020 Q3 20,702,215 $101,025,000 +$1,419,388 $4.88 48
2020 Q2 20,376,511 $137,129,000 +$1,373,165 $6.73 38
2020 Q1 20,094,996 $138,851,000 +$7,076,949 $6.91 46
2019 Q4 19,092,604 $162,661,000 +$3,264,167 $8.52 48
2019 Q3 18,791,229 $93,011,000 +$3,301,097 $4.95 36
2019 Q2 16,643,596 $92,372,000 +$5,729,192 $5.55 37
2019 Q1 17,840,046 $90,090,000 -$29,758,901 $5.05 38
2018 Q4 20,248,444 $191,350,000 +$11,483,390 $9.45 38
2018 Q3 19,139,638 $153,117,000 +$63,511,421 $8.00 32
2018 Q2 10,991,993 $102,314,000 -$2,765,525 $9.31 15
2018 Q1 11,284,927 $116,687,000 +$956,972 $10.34 18
2017 Q4 11,172,927 $143,012,000 +$18,288,209 $12.80 21
2017 Q3 9,744,158 $109,858,000 -$3,309,394 $11.24 15
2017 Q2 10,277,545 $90,441,000 -$2,133,967 $8.80 17
2017 Q1 10,506,484 $108,526,311 +$17,829,524 $10.36 19
2016 Q4 8,747,097 $112,668,000 +$8,278,863 $12.98 19
2016 Q3 8,240,474 $131,195,529 +$131,195,678 $16.47 32